What is Wegovy?
Wegovy is an innovative, clinically proven prescription medication designed for weight loss and long-term weight management. Its active ingredient is semaglutide, a GLP-1 (Glucagon-Like Peptide-1) receptor agonist.
While semaglutide is also used in diabetes care, Wegovy is specifically formulated, clinically trialed, and authorised in the EU for treating obesity and overweight.
How does Wegovy work?
Wegovy mimics the action of GLP-1, a natural hormone produced in your gut after eating. It supports your weight loss journey in several key ways:
Appetite Regulation: It targets the areas of the brain that control hunger and satiety, reducing overall appetite and cravings.
Delayed Gastric Emptying: It slows down the rate at which food leaves your stomach, helping you feel full faster and stay satisfied for longer.
Reduced Food Cravings: It helps lower the desire for high-calorie, fatty, or sugary foods.
Who is Wegovy suitable for?
Wegovy is prescribed under professional medical supervision for adults who meet the following clinical criteria:
A BMI of 30 or higher (obesity).
A BMI of 27 or higher (overweight) accompanied by at least one weight-related medical condition (such as high blood pressure, high cholesterol, sleep apnea, or prediabetes).
How is Wegovy administered?
Wegovy is administered as a once-weekly subcutaneous injection on a fixed day of the week using a pre-filled pen (injected into the abdomen, thigh, or upper arm).
Treatment always begins at a low starting dose (0.25 mg) and is gradually increased over several months (dose escalation schedule). This step-by-step approach allows your body to adjust comfortably and helps minimize mild digestive side effects like nausea.
💡 Learn more: Ready to see if Wegovy is right for you? Complete your online medical consultation today or check your application status in your Wellis account portal.